ScoreWhy is Divis Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 17.24%
2
The company is Net-Debt Free
3
The company has declared Positive results for the last 7 consecutive quarters
- NET SALES(Q) Highest at Rs 2,831.00 cr
- PBDIT(Q) Highest at Rs 934.00 cr.
- PBT LESS OI(Q) Highest at Rs 808.00 cr.
4
High Institutional Holdings at 39.51%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating performance in long term as well as near term
- Along with generating 5.18% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
6
With its market cap of Rs 1,83,306 cr, it is the second biggest company in the sector (behind Sun Pharma.Inds.)and constitutes 7.12% of the entire sector
- Its annual Sales of Rs 10,314.00 are 2.13% of the industry
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Divi's Lab. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Divi's Lab. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Divi's Lab.
5.04%
0.26
21.65%
Sensex
-6.68%
-0.51
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.44%
EBIT Growth (5y)
4.68%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.67
Tax Ratio
24.63%
Dividend Payout Ratio
49.69%
Pledged Shares
0
Institutional Holding
39.51%
ROCE (avg)
27.54%
ROE (avg)
17.24%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
72
Industry P/E
34
Price to Book Value
11.89
EV to EBIT
61.21
EV to EBITDA
53.09
EV to Capital Employed
14.71
EV to Sales
17.47
PEG Ratio
3.20
Dividend Yield
0.43%
ROCE (Latest)
22.99%
ROE (Latest)
16.12%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(Q)
Highest at Rs 2,831.00 cr
PBDIT(Q)
Highest at Rs 934.00 cr.
PBT LESS OI(Q)
Highest at Rs 808.00 cr.
PAT(Q)
Highest at Rs 751.00 cr.
EPS(Q)
Highest at Rs 28.34
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Divi's Lab.
Net Sales - Quarterly
Highest at Rs 2,831.00 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 934.00 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 808.00 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 751.00 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 28.34
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Divi's Lab.
Non Operating Income - Quarterly
Highest at Rs 155.00 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
